CIP
TNDM icon

Chartwell Investment Partners’s Tandem Diabetes Care TNDM Stock Holding History

Chartwell Investment Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,423
Closed -$870K – 432
2023
Q1 		$870K Buy
21,423
+716
+3% +$29.6K 0.03% 354
2022
Q4 		$931K Sell
20,707
-14,717
-42% -$666K 0.04% 348
2022
Q3 		$1.7M Buy
35,424
+6,882
+24% +$377K 0.07% 284
2022
Q2 		$1.69M Buy
28,542
+11,495
+67% +$944K 0.07% 290
2022
Q1 		$1.98M Buy
17,047
+713
+4% +$83.2K 0.07% 296
2021
Q4 		$2.46M Sell
16,334
-443
-3% -$59.8K 0.07% 279
2021
Q3 		$2M Hold
16,777
– – 0.06% 289
2021
Q2 		$1.63M Buy
16,777
+156
+0.9% +$13.9K 0.05% 322
2021
Q1 		$1.47M Sell
16,621
-893
-5% -$83K 0.04% 329
2020
Q4 		$1.68M Sell
17,514
-3,988
-19% -$411K 0.05% 303
2020
Q3 		$2.44M Hold
21,502
– – 0.09% 250
2020
Q2 		$2.13M Sell
21,502
-6,296
-23% -$502K 0.08% 263
2020
Q1 		$1.79M Buy
27,798
+2,720
+11% +$191K 0.08% 263
2019
Q4 		$1.5M Sell
25,078
-33,534
-57% -$2.07M 0.05% 322
2019
Q3 		$3.46M Hold
58,612
– – 0.12% 240
2019
Q2 		$3.78M Buy
58,612
+3,519
+6% +$227K 0.12% 236
2019
Q1 		$3.5M Buy
55,093
+747
+1% +$39.2K 0.11% 248
2018
Q4 		$2.06M Sell
54,346
-19,572
-26% -$691K 0.07% 328
2018
Q3 		$3.17M Sell
73,918
-79,818
-52% -$2.79M 0.09% 296
2018
Q2 		$3.38M Sell
153,736
-103,990
-40% -$1.28M 0.1% 270
2018
Q1 		$1.28M Buy
+257,726
New +$831K 0.04% 354

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Chartwell Investment Partners's TNDM Position: Q2 2023 in Review

Chartwell Investment Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 21,423 shares — an estimated $870K sold.

Chartwell Investment Partners first reported a position in TNDM in Q1 2018 and held it in 21 quarters. The position peaked at $3.78M in Q2 2019. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Chartwell Investment Partners reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Chartwell Investment Partners sold 21,423 Tandem Diabetes Care shares in Q2 2023, an estimated $870K.
  • Chartwell Investment Partners first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 21 quarters.
  • Chartwell Investment Partners's Tandem Diabetes Care position peaked at $3.78M in Q2 2019.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Chartwell Investment Partners's 13F filing for Q2 2023, filed 25 Jul 2023.